Neurology – MedMeetings

Bipolar Disorder’s Illness Duration and Mood Instability Impact Neurometabolic Response to Methylene Blue Assessed with Quantitative Neuroimaging

A study reporting complex relationship between bipolar disorder (BD) progression and brain metabolism was presented by Dr Alfonso Russo, et al., from the Brighton and

Investigation of Malondialdehyde (MDA) as a Trait Phenomenon Associated with Familial Risk in Patients with Newly Diagnosed Bipolar Disorder and their Unaffected First-Degree Relatives

A prospective study on the role of oxidative stress in Bipolar disorder (BD) was presented by Drs Klara Coello, Sharleny Stanislaus, et al., from the

Blue-Blocking Glasses as Adjunct to Lithium in Preventive Treatment for Bipolar Disorder

This study was presented by Drs Tone Elise Henriksen, and Tuva Maria Martinussen from the Valen Hospital, Fonna Hospital Trust, at the 2024 Annual Meeting

The Role of Gaba-A Allosteric Modulators in the Case Management of Depressive Disorders – Clinical Recommendations and Future Perspectives

A review on allopregnanolone agonists was presented by Drs Octavian Vasiliu, Andrei Gabriel Mangalagiu, et al., from the University Emergency Central Military Hospital Carol Davila

Toludesvenlafaxine–AnInnovative Agent or JustAnother “Me, too”Drug?

A review on a novel antidepressant was presented by Drs Daniel Vasile, Octavian Vasiliu, Diana Vasiliu from the University of Medicine and Pharmacy Carol Davila,

Peripheral Insulin Sensitivity Modulates Effort-Based Behavioural Response to Intranasal Insulin in Individuals with Mood Disorders

A study on the complex relationship between mood disorders and metabolic conditions was presented by Drs Aniqa Tabassum, Joshua Di Vincenzo, et al., from the

Effect of Immersive Virtual Reality-Based Cognitive Remediation in Patients with Moodor Psychosis Spectrum Disorders: Study Protocol for a Randomized, Controlled, Double- Blinded Trial

The trial results exploring the potential of virtual reality (VR) in improving mood and psychosis spectrum disorders was presented by Dr Andreas Jespersen et al.,

Intracortical Myelin as a Neurobiological Mechanism of Relapse in Bipolar I Disorder: A 2-Year Longitudinal Study

A study on the relationship between intracortical myelin (ICM) changes and relapse in individuals with bipolar I disorder (BD-I) was presented by Drs Benicio N.

Unsupervised Stratification of Bipolar and Major Depressive Disorders Based on Gene-environment and Multimodal Neuroimaging Signatures

A study on the genetic-environmental and cerebral underpinnings of bipolar disorder and major depressive disorder was presented by Dr Eleonora Maggioni, et al., from Politecnico

Lithium and Lamotrigine for the Treatment of Bipolar Disorder, Type II-A Systematic Review and Meta-Analysis of Randomized Trials

A systematic review and meta-analysis on the treatment of bipolar disorder (BDII) was presented by Dr Mette Fredskild, et al., from the Copenhagen Affective Disorders